Calcitriol NDC 62756-968

NDC codes

FDA NDC Directory

Product NDC (as listed)62756-968Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62756-0968Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62756-968-18	62756096818	1000 CAPSULE, LIQUID FILLED in 1 BOTTLE (62756-968-18)Marketed from May 1, 2020
62756-968-83	62756096883	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (62756-968-83)Marketed from May 1, 2020
62756-968-88	62756096888	100 CAPSULE, LIQUID FILLED in 1 BOTTLE (62756-968-88)Marketed from May 1, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcitriol
Generic name (nonproprietary): calcitriol
Active ingredients: Calcitriol — .5 ug/1
Dosage form: Capsule, Liquid filled
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204556
Marketing start: May 1, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Cholecalciferol (Chemical structure)
Identifiers: Product ID 62756-968_fb99b865-fb41-4c92-8db9-7953feed2394SPL ID fb99b865-fb41-4c92-8db9-7953feed2394SPL set ID 97cf7807-3b48-403b-bae2-2fe585946e0cRxCUI 308867, 308868UNII FXC9231JVHUPC 0362756968882, 0362756967885
Pharmacologic class: Vitamin D3 Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462756096818 followed by a unit qualifier and the quantity

Package 62756-0968-18. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 17, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Predialysis Patients Calcitriol is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥ 100 pg/mL is strongly suggestive of secondary hyperparathyroidism. Dialysis Patients Calcitriol is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces ser…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204556

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204556
Product	Strength	Form · route	Labeler	Product NDC
Calcitriol	Calcitriol .25 ug/1	Capsule, Liquid filledOral	Sun Pharmaceutical Industries, Inc.	62756-967